Enright Patrick G Insider Trades

Insider Trading History

Track insider trading activity for Enright Patrick G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $184k 5,882 shares
Last Trade
Dec 11, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$250k 5,882 shares
$42.50
$31.27
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $31.9M 1,832,669 shares
Last Trade
Oct 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.25M 117,255 shares
$27.76
$17.40
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $4.94M 21,379 shares
Last Trade
Aug 18, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$588k 5,000 shares
$117.67
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $6.09M 26,379 shares
Last Trade
Aug 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$201k 1,805 shares
$111.25
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $6.51M 28,184 shares
Last Trade
Aug 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$393k 3,507 shares
$112.08
$230.93
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $112M 3,596,593 shares
Last Trade
Jun 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$908k 40,607 shares
$22.35
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $112M 3,569,522 shares
Last Trade
Jun 23, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.37M 209,393 shares
$20.87
$31.27
Zenas BioPharma
Zenas BioPharma ZBIO
Director
Holding Value $322k 18,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 18,500 shares
$11.94
$17.40
BioAge Labs
BioAge Labs BIOA
Director
Holding Value $353k 22,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.7k 22,000 shares
$4.44
$16.04
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $438k 14,000 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 14,000 shares
$21.19
$31.27
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $5.7M 24,677 shares
Last Trade
Aug 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 3,731 shares
$113.26
$230.93
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $438k 14,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 14,000 shares
$42.69
$31.27
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $4.84M 20,946 shares
Last Trade
Aug 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$171k 1,241 shares
$138.16
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $5.12M 22,187 shares
Last Trade
Aug 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 3,075 shares
$139.35
$230.93
Vera Therapeutics
Vera Therapeutics VERA
10% owner
Holding Value $625k 20,000 shares
Last Trade
May 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 20,000 shares
$7.70
$31.27
Vera Therapeutics
Vera Therapeutics VERA
10% owner
Holding Value $53.6M 1,714,285 shares
Last Trade
Feb 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12M 1,714,285 shares
$7.00
$31.27
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $4.89M 21,181 shares
Last Trade
Nov 22, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.05M 6,974 shares
$150.45
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $5.56M 24,086 shares
Last Trade
Aug 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$166k 1,089 shares
$152.33
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $5.81M 25,175 shares
Last Trade
Aug 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$394k 2,561 shares
$153.72
$230.93
Aptinyx
Aptinyx APTX
Director
Holding Value $3.84k 40,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 40,000 shares
$0.50
$0.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up